Physician profile
Mehrun Elyaderani
NPI 1235147604
$2,335.57
in general payments reported to CMS, 2019-2025
8 companies · $451 in 2025
The $451 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $128 · 2021: $294 · 2022: $243 · 2023: $489 · 2024: $137 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,062.90 | 2019-2025 | Mako, Accolade, Blueprint Patient Specific Instrumentation |
| Smith+Nephew, INC. | $619.15 | 2019-2023 | Panta 2, Tandem, Redapt |
| Checkpoint Surgical, INC | $137.38 | 2024 | Checkpoint Stimulators |
| Djo, LLC | $126.31 | 2021 | |
| Polynovo North America LLC | $122.57 | 2023 | |
| Endo USA, INC. | $122.49 | 2025 | Xiaflex |
| Horizon Therapeutics Plc | $120.78 | 2019 | |
| Depuy Synthes Sales INC. | $23.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehrun Elyaderani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.